SYSTEMS AND METHODS FOR ABLATING BODY TISSUE
    2.
    发明申请
    SYSTEMS AND METHODS FOR ABLATING BODY TISSUE 有权
    用于排除身体组织的系统和方法

    公开(公告)号:US20130261455A1

    公开(公告)日:2013-10-03

    申请号:US13907412

    申请日:2013-05-31

    申请人: VytronUS, Inc.

    摘要: A transducer subassembly with combined imaging and therapeutic capabilities is disclosed. The subassembly includes heat sinks that are configured to maintain the transducer at a low operating temperature so that the transducer operates at high efficiency and also can handle a wider range of frequencies. The subassembly is also configured to allow cooling fluid to flow past the transducer element. One heat sink in the subassembly also acts as an acoustic matching layer and another heat sink acts as a backing Alternatively, the second heat sink which acts as a backing is optional. The transducer is configured to transmit at one power level for imaging, and at a second power level for ablating. The transducer may comprise sub-elements transmitting at different power levels. The subassembly may be operated at one power level for imaging and a second power level for ablating.

    摘要翻译: 公开了具有组合成像和治疗能力的传感器子组件。 子组件包括散热器,其被配置为将换能器保持在低工作温度,使得换能器以高效率运行并且还可以处理更宽的频率范围。 该子组件还构造成允许冷却流体流过换能器元件。 子组件中的一个散热器还用作声匹配层,另一散热器用作背衬。或者,用作背衬的第二散热器是可选的。 换能器被配置为以一个功率电平进行成像传输,并且在第二功率电平下进行烧蚀。 换能器可以包括以不同功率电平发送的子元件。 子组件可以在用于成像的一个功率水平下操作和用于烧蚀的第二功率水平。

    Methods for imaging and ablating body tissue

    公开(公告)号:US10154831B2

    公开(公告)日:2018-12-18

    申请号:US15669675

    申请日:2017-08-04

    申请人: VytronUS, Inc.

    摘要: A method for creating a transmural lesion in tissue includes positioning a distal portion of a catheter near the tissue, where an ultrasound transducer is attached to the distal portion and is operatively coupled to a console and processor. The tissue is imaged by energizing the ultrasound transducer at a first power level to produce an ultrasound beam, where the imaging determines a thickness of the tissue, and a gap distance between the ultrasound transducer and the tissue. The tissue is ablated by energizing the ultrasound transducer at a second power level to produce the ultrasound beam. Energy delivered to the tissue during the ablating is controlled, using the processor, where the processor adjusts a speed of the ultrasound beam moving across the tissue based on the thickness and gap distance, to create the transmural lesion.